Shahriar A. Zamani, Ph.D.

Shahriar Zamani, Ph.D., joined NCI in 2023 as a postdoctoral Cancer Prevention Fellow in the Radiation Epidemiology Branch (REB) and subsequently joined the Integrative Tumor Epidemiology Branch (ITEB). Dr. Zamani earned a B.S. in public health from the University of South Florida, Tampa, in 2018 and a Ph.D. in oncology in 2023 from the University of Cambridge, England, where he was a Gates-Cambridge Scholar. His graduate school research focused on the role of environmental, lifestyle, and genomic factors in the etiology and outcomes of esophageal adenocarcinoma and its precursor, known as Barrett’s esophagus.

As a postdoctoral fellow in REB, Dr. Zamani examined the germline genetic variation in relation to risk of subsequent neoplasms among childhood cancer survivors. In 2024, he was awarded a Scholar-in-Training Award from the American Association for Cancer Research and an NIH Fellows’ Award for Research Excellence. Additionally, he is researching the genomic landscape of thyroid malignancies occurring after the Chernobyl nuclear power plant accident, under the mentorship of Lindsay Morton, Ph.D., REB Director, and Senior Investigator. In ITEB, Dr. Zamani is working with Mitchell Machiela, Sc.D., M.P.H., Senior Investigator, to characterize chromosomal loss across solid tumors.